======= NDUFA13 ======= == Gene Information == * **Official Symbol**: NDUFA13 * **Official Name**: N/ADH:ubiquinone oxidoreductase subunit A13 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51079|51079]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P0J0|Q9P0J0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NDUFA13&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NDUFA13|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609435|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), which functions in the transfer of electrons from NADH to the respiratory chain. The protein is required for complex I assembly and electron transfer activity. The protein binds the signal transducers and activators of transcription 3 (STAT3) transcription factor, and can function as a tumor suppressor. The human protein purified from mitochondria migrates at approximately 16 kDa. Transcripts originating from an upstream promoter and capable of expressing a protein with a longer N-terminus have been found, but their biological validity has not been determined. [provided by RefSeq, Oct 2009]. * **UniProt Summary**: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis (PubMed:27626371). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:27626371). Involved in the interferon/all-trans-retinoic acid (IFN/RA) induced cell death. This apoptotic activity is inhibited by interaction with viral IRF1. Prevents the transactivation of STAT3 target genes. May play a role in CARD15-mediated innate mucosal responses and serve to regulate intestinal epithelial cell responses to microbes (PubMed:15753091). {ECO:0000269|PubMed:12628925, ECO:0000269|PubMed:12867595, ECO:0000269|PubMed:15753091, ECO:0000269|PubMed:27626371}. |GRIM-19| |protein insertion into mitochondrial inner membrane| |NADH dehydrogenase activity| |mitochondrial respirasome| |establishment of protein localization to mitochondrial membrane| |cellular response to interferon-beta| |protein insertion into mitochondrial membrane| |response to interferon-beta| |protein insertion into membrane| |inner mitochondrial membrane organization| |NADH dehydrogenase (ubiquinone) activity| |mitochondrial electron transport, NADH to ubiquinone| |mitochondrial respiratory chain complex I| |protein targeting to mitochondrion| |NADH dehydrogenase complex assembly| |mitochondrial respiratory chain complex I assembly| |cellular response to retinoic acid| |establishment of protein localization to mitochondrion| |protein localization to mitochondrion| |mitochondrial ATP synthesis coupled electron transport| |ATP synthesis coupled electron transport| |negative regulation of intrinsic apoptotic signaling pathway| |extrinsic apoptotic signaling pathway| |mitochondrial respiratory chain complex assembly| |mitochondrial membrane| |response to retinoic acid| |respiratory electron transport chain| |reactive oxygen species metabolic process| |oxidative phosphorylation| |mitochondrial membrane organization| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process| |positive regulation of cysteine-type endopeptidase activity| |regulation of intrinsic apoptotic signaling pathway| |cellular respiration| |positive regulation of endopeptidase activity| |electron transport chain| |negative regulation of cell growth| |positive regulation of peptidase activity| |ATP metabolic process| |cellular response to acid chemical| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |mitochondrial transport| |positive regulation of protein catabolic process| |negative regulation of apoptotic signaling pathway| |energy derivation by oxidation of organic compounds| |regulation of cysteine-type endopeptidase activity| |negative regulation of growth| |establishment of protein localization to membrane| |apoptotic signaling pathway| |response to acid chemical| |protein targeting| |positive regulation of proteolysis| |regulation of protein catabolic process| |mitochondrial inner membrane| |regulation of apoptotic signaling pathway| |regulation of cell growth| |regulation of endopeptidase activity| |generation of precursor metabolites and energy| |establishment of protein localization to organelle| |positive regulation of catabolic process| |mitochondrion organization| |regulation of peptidase activity| |protein localization to membrane| |negative regulation of intracellular signal transduction| |cellular response to lipid| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of growth| |positive regulation of cell death| |regulation of proteolysis| |protein localization to organelle| |positive regulation of hydrolase activity| |cellular protein-containing complex assembly| |membrane organization| |response to lipid| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |apoptotic process| |oxidation-reduction process| |intracellular protein transport| |negative regulation of cell death| |regulation of catabolic process| |cellular response to cytokine stimulus| |programmed cell death| |cellular response to oxygen-containing compound| |cell death| |response to cytokine| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |mitochondrion| |negative regulation of signal transduction| |regulation of hydrolase activity| |phosphorylation| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |positive regulation of catalytic activity| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |ATP binding| |protein transport| |negative regulation of cellular biosynthetic process| |intracellular transport| |peptide transport| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of programmed cell death| |amide transport| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |negative regulation of response to stimulus| |regulation of cell death| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of molecular function| |regulation of intracellular signal transduction| |establishment of localization in cell| |nitrogen compound transport| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.72| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.79| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.83| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.85| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.85| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.89| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|1.93| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.98| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.1| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.11| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|2.15| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|2.17| |[[:results:exp495|IWR1 50μM R08 exp495]]|2.19| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.22| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|2.44| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.46| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|2.55| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.79| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|3.27| ^Gene^Correlation^ |[[:human genes:n:ndufc2|NDUFC2]]|0.589| |[[:human genes:n:ndufa2|NDUFA2]]|0.567| |[[:human genes:n:ndufa1|NDUFA1]]|0.55| |[[:human genes:n:ndufs2|NDUFS2]]|0.538| |[[:human genes:n:ndufa11|NDUFA11]]|0.535| |[[:human genes:n:ndufb4|NDUFB4]]|0.533| |[[:human genes:n:ndufa9|NDUFA9]]|0.533| |[[:human genes:n:ndufb11|NDUFB11]]|0.525| |[[:human genes:a:acad9|ACAD9]]|0.518| |[[:human genes:n:ndufb9|NDUFB9]]|0.515| |[[:human genes:n:nubpl|NUBPL]]|0.513| |[[:human genes:n:ndufaf7|NDUFAF7]]|0.503| |[[:human genes:n:ndufs8|NDUFS8]]|0.501| |[[:human genes:n:ndufb7|NDUFB7]]|0.5| |[[:human genes:r:rtn4ip1|RTN4IP1]]|0.499| |[[:human genes:n:ndufa8|NDUFA8]]|0.497| |[[:human genes:g:grsf1|GRSF1]]|0.496| |[[:human genes:n:ndufc1|NDUFC1]]|0.496| |[[:human genes:m:mto1|MTO1]]|0.49| |[[:human genes:n:ndufa3|NDUFA3]]|0.485| |[[:human genes:n:ndufv1|NDUFV1]]|0.476| |[[:human genes:t:timmdc1|TIMMDC1]]|0.476| |[[:human genes:n:ndufs1|NDUFS1]]|0.468| |[[:human genes:n:ndufs5|NDUFS5]]|0.467| |[[:human genes:n:ndufb8|NDUFB8]]|0.466| |[[:human genes:n:ndufa10|NDUFA10]]|0.462| |[[:human genes:n:ndufa6|NDUFA6]]|0.457| |[[:human genes:n:ndufaf3|NDUFAF3]]|0.456| |[[:human genes:n:ndufs3|NDUFS3]]|0.451| |[[:human genes:n:ndufs7|NDUFS7]]|0.444| |[[:human genes:n:noa1|NOA1]]|0.443| |[[:human genes:e:ecsit|ECSIT]]|0.443| |[[:human genes:m:mtrf1l|MTRF1L]]|0.441| |[[:human genes:n:ndufv2|NDUFV2]]|0.441| |[[:human genes:t:tfb1m|TFB1M]]|0.43| |[[:human genes:n:ndufaf6|NDUFAF6]]|0.429| |[[:human genes:p:polg2|POLG2]]|0.427| |[[:human genes:m:mrpl45|MRPL45]]|0.427| |[[:human genes:n:ndufb2|NDUFB2]]|0.425| |[[:human genes:s:slc25a51|SLC25A51]]|0.422| |[[:human genes:m:mrps27|MRPS27]]|0.419| |[[:human genes:t:tmem261|TMEM261]]|0.418| |[[:human genes:m:mrpl43|MRPL43]]|0.418| |[[:human genes:m:mrp63|MRP63]]|0.414| |[[:human genes:r:rnmtl1|RNMTL1]]|0.414| |[[:human genes:m:mrps21|MRPS21]]|0.413| |[[:human genes:n:ndufaf4|NDUFAF4]]|0.409| |[[:human genes:n:ndufa5|NDUFA5]]|0.409| |[[:human genes:m:mtif2|MTIF2]]|0.408| |[[:human genes:w:wbscr16|WBSCR16]]|0.405| |[[:human genes:m:mrpl3|MRPL3]]|0.403| |[[:human genes:m:mettl17|METTL17]]|0.403| |[[:human genes:c:c10orf2|C10orf2]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 248 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}